The oral route exposes the GI tract to higher local concentrations of semaglutide, which can trigger more nausea, vomiting, and diarrhea
While NAD+ addresses core cellular vitality and repair, and AOD9604 targets metabolic fat regulation, their combined effects could, in theory, offer a more comprehensive approach to health optimization
Having a metabolic disease such as obesity or type 2 diabetes, as well as a low-choline, methionine, or inositol diet, can make weight loss difficult
However, research supporting their efficacy is limited, and they are generally not recommended for those with severe deficiencies
Its use should be avoided unless specifically recommended by a healthcare provider after a careful risk-benefit assessment